Skip to content
Recall Observatory FDA recall evidence

Drug product

Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR

D-0471-2026

March 06, 2026

Class II

Product summary

Firm
PAYLESS COMPOUNDERS, LLC
Event
Event 98646
Status
Ongoing
Classification
Class II
Quantity
91 vials
Official record key
drug-enforcement:D-0471-2026

Official wording

Reason: Lack of Assurance of Sterility

Code information: Lot Number 01-27-2026@14S.5

Distribution pattern: OR

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility